I think you’re right. China is banking on the NGIO vaccine to work. I believe they plan on using the NGIO vaccine as part of the 2 billion dose package they will be selling to COVAX in early 2022. Their own vaccines are worthless and they’ve already made a public commitment to COVAX. NGIO will save the day!
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links